✦ LIBER ✦

621 POSTER A phase I study of combination therapy with AEE788, a novel multitargeted inhibitor of ErbB and VEGF receptor family tyrosine kinases, and RAD001, a mTOR inhibitor in recurrent GBM patients

✍ Scribed by D. Reardon; T. Cloughesy; J. Rich; W. Yung; C. Cilea; W. Mietlowski; L. Yung; W. Chen; A. Lai; C. Conrad

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of AEE788, a novel multita

✍ Reardon, David A.; Conrad, Charles A.; Cloughesy, Timothy; Prados, Michael D.; F 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 416 KB

387 A phase I study of AEE788, a novel m

✍ H. Dumez; P. Clement; C.H. Takimoto; A.T. van Oosterom; A. Mita; K. Parker; E.K. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 147 KB

412 A phase I and pharmacokinetic study

✍ A. Mita; C.H. Takimoto; E. Martinelli; H. Dumez; C. DiLea; W. Mietlowski; J. Tab 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 149 KB

35 POSTER A Phase I trial of a combinati

✍ G. Dy; G. Croghan; A. Furth; J. Reid; L. Hanson; M. Roos; A. Tan; A. Adjei 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 134 KB

704 POSTER A phase I dose escalation and

✍ E. Raymond; F. Goldwasser; G. Bousquet; C. Le Tourneau; S. Faivre; H. de-Montser 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 64 KB